These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27699567)

  • 1. Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort.
    Achelrod D; Schreyögg J; Stargardt T
    Eur J Health Econ; 2017 Sep; 18(7):869-882. PubMed ID: 27699567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home telemonitoring effectiveness in COPD: a systematic review.
    Cruz J; Brooks D; Marques A
    Int J Clin Pract; 2014 Mar; 68(3):369-78. PubMed ID: 24472009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany.
    Hofer F; Achelrod D; Stargardt T
    Appl Health Econ Health Policy; 2016 Dec; 14(6):691-701. PubMed ID: 27475635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)-A large population-based cohort study.
    Achelrod D; Welte T; Schreyögg J; Stargardt T
    Health Policy; 2016 Sep; 120(9):1029-39. PubMed ID: 27552849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small-scale randomised controlled trial of home telemonitoring in patients with severe chronic obstructive pulmonary disease.
    Shany T; Hession M; Pryce D; Roberts M; Basilakis J; Redmond S; Lovell N; Schreier G
    J Telemed Telecare; 2017 Aug; 23(7):650-656. PubMed ID: 27464957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a home telemonitoring program for patients with chronic obstructive pulmonary disease in Germany: Evidence from the first three years.
    Hofer F; Schreyögg J; Stargardt T
    PLoS One; 2022; 17(5):e0267952. PubMed ID: 35551546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the National Health Service (NHS) Direct Pilot Telehealth Program: Cost-Effectiveness Analysis.
    Clarke M; Fursse J; Brown-Connolly NE; Sharma U; Jones R
    Telemed J E Health; 2018 Jan; 24(1):67-76. PubMed ID: 28723244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised clinical trial of the effectiveness of home-based health care with telemonitoring in patients with COPD.
    McDowell JE; McClean S; FitzGibbon F; Tate S
    J Telemed Telecare; 2015 Mar; 21(2):80-7. PubMed ID: 25586812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a chronic obstructive pulmonary disease integrated care pathway in a regional health system: a propensity score matched cohort study.
    Wu CX; Hwang CH; Tan WS; Tai KP; Kwek LSL; Chee TG; Choo YM; Phng FWL; Chua GSW
    BMJ Open; 2018 Mar; 8(3):e019425. PubMed ID: 29572394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).
    Friedman M; Menjoge SS; Anton SF; Kesten S
    Pharmacoeconomics; 2004; 22(11):741-9. PubMed ID: 15250751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial.
    Ringbæk T; Green A; Laursen LC; Frausing E; Brøndum E; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1801-8. PubMed ID: 26366072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare utilization, medical costs and mortality associated with malnutrition in patients with chronic obstructive pulmonary disease: a matched cohort study.
    Jerng JS; Tang CH; Cheng RW; Wang MY; Hung KY
    Curr Med Res Opin; 2019 Jul; 35(7):1265-1273. PubMed ID: 30676096
    [No Abstract]   [Full Text] [Related]  

  • 16. Does home telemonitoring after pulmonary rehabilitation reduce healthcare use in optimized COPD? A pilot randomized trial.
    Lewis KE; Annandale JA; Warm DL; Rees SE; Hurlin C; Blyth H; Syed Y; Lewis L
    COPD; 2010 Feb; 7(1):44-50. PubMed ID: 20214462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
    Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct medical costs of COPD--an excess cost approach based on two population-based studies.
    Menn P; Heinrich J; Huber RM; Jörres RA; John J; Karrasch S; Peters A; Schulz H; Holle R;
    Respir Med; 2012 Apr; 106(4):540-8. PubMed ID: 22100535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.